Department of Urology, Academic Medical Center, Amsterdam, the Netherlands.
J Endourol. 2011 Nov;25(11):1733-40. doi: 10.1089/end.2011.0225. Epub 2011 Aug 18.
To define in which patients who present with microscopic or macroscopic hematuria CT urography (CTU) is indicated as an imaging mode for the upper urinary tract (UUT).
We conducted a prospective study on consecutive patients who attended a modern protocol-driven hematuria clinic from January 2006 to February 2010. Standard tests (history taking, physical examination, urinalysis via dipstick method, ultrasonography of kidneys and bladder performed by urologists, cystoscopy, and cytology) were directed to all patients, whereas the mode of additional UUT imaging (ultrasonography by a radiologist or four-phase CTU/magnetic resonance (MR) urography (MRU) when CTU was contraindicated) was selected according to a risk factor-based management algorithm. The added value of cross-sectional urography (CTU/MRU) supplementary to ultrasonography (by urologists) to detect renal masses, UUT tumors, and stones was assessed. Univariate and multivariate analysis on predictive factors for cross-sectional urography result were performed.
From the total of 841 patients, lesions that might account for hematuria could not be identified in 462 (54.9%), whereas in 250 (29.7%) and 124 (14.7%) patients, hematuria was from benign and malignant disease, respectively. Cross-sectional urography revealed relevant UUT lesions in 73 of 525 (13.9%) patients. Only result of ultrasonography (odds ratio [OR] 7.7, 95% confidence interval [CI] 4.0-14.9), P<0.001) and type of hematuria (OR 2.6, 95% CI 1.3-5.1, P=0.01) were significant predictors for cross-sectional urography result. In 44 of 456 (9.6%) patients with no abnormalities on ultrasonography, CTU/MRU revealed that these were false negatives, with most lesions missed being stones. In 253 of 309 (81.9%) patients with macroscopic hematuria, no lesions were detected in the UUT on CTU/MRU, in contrast to 199 of 216 patients (92.1%) with microscopic hematuria.
For patients who present with microscopic hematuria, ultrasonography is sufficient to exclude significant UUT disease. For patients with macroscopic hematuria, the likelihood of finding UUT disease is higher, and a CTU as a first-line test seems justified.
明确在哪些出现镜下或肉眼血尿的患者中,CT 尿路造影(CTU)是上尿路(UUT)的首选影像学检查方法。
我们对 2006 年 1 月至 2010 年 2 月期间参加现代方案驱动血尿门诊的连续患者进行了前瞻性研究。对所有患者进行了标准检查(病史、体格检查、尿液分析、泌尿科医生进行的肾脏和膀胱超声检查、膀胱镜检查和细胞学检查),而根据基于危险因素的管理算法,选择了 UUT 额外成像(放射科医生进行的超声检查或有 CTU 禁忌时的四期 CTU/磁共振尿路造影(MRU))方式。评估横断面尿路造影(CTU/MRU)对超声检查(泌尿科医生)发现肾脏肿块、UUT 肿瘤和结石的补充价值。对横断面尿路造影结果的预测因素进行了单变量和多变量分析。
在总共 841 例患者中,462 例(54.9%)患者的血尿原因无法确定,250 例(29.7%)和 124 例(14.7%)患者的血尿分别来自良性和恶性疾病。在 525 例患者中,横断面尿路造影显示有相关的 UUT 病变 73 例(13.9%)。只有超声检查结果(比值比[OR]7.7,95%置信区间[CI]4.0-14.9)和血尿类型(OR 2.6,95%CI 1.3-5.1,P=0.01)是横断面尿路造影结果的显著预测因素。在 44 例超声检查无异常的 456 例患者中,CTU/MRU 显示这些为假阴性,大多数漏诊的病变为结石。在 253 例肉眼血尿患者中,在 UUT 中未发现病变,而在 216 例镜下血尿患者中,199 例(92.1%)未发现病变。
对于出现镜下血尿的患者,超声检查足以排除 UUT 疾病。对于出现肉眼血尿的患者,发现 UUT 疾病的可能性更高,因此作为一线检查,CTU 似乎是合理的。